Werewolf Therapeutics rises on plans to explore strategic alternatives
24/02/2026 21:48
** Shares of biotech co Werewolf Therapeutics HOWL.O rise 7.3% to 71 cents in after-hours trading
** Co says it will explore a full range of strategic alternatives to advance its drug development pipeline
** Co says "measures may include, among other options, a sale of the company, a business combination or merger, a sale of assets, licensing or collaboration arrangements, or other strategic transactions"
** Co says it does not have a defined timeline for the review
** Co has engaged Piper Sandler & Co to serve as financial adviser
** Stock rose 57.2% in 2025
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com;))